|
|
||||||||
From the Peripheral Neuropathy Research Laboratory, Mayo Clinic and Mayo Foundation, Rochester, MN.
Address correspondence and reprint requests to Dr. P.J. Dyck, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
OBJECTIVE: To determine whether microscopic vasculitis explains the clinical and pathologic features of diabetic lumbosacral radiculoplexus neuropathy (DLSRPN).
BACKGROUND: DLSRPN is usually attributed to metabolic derangement or ischemic injury, but microscopic vasculitis as the sole cause needs consideration.
METHODS: We prospectively studied the clinical, laboratory, and EMG features as well as the pathology of distal cutaneous nerve biopsy specimens of patients with DLSRPN.
RESULTS: Study of DLSRPN nerve biopsy specimens (n = 33) compared with those from healthy controls (n = 14) and those with diabetic polyneuropathy (n = 21) provided strong evidence for ischemic injury (axonal degeneration, multifocal fiber loss, focal perineurial necrosis and thickening, injury neuroma, neovascularization, and swollen fibers with accumulated organelles), which we attribute to microscopic vasculitis (epineurial vascular and perivascular inflammation, vessel wall necrosis, and evidence of previous bleeding). Segmental demyelination was significantly associated with multifocal fiber loss.
CONCLUSIONS: 1) This severe, debilitating neuropathy begins with symptoms unilaterally and focally in the leg, thigh, or buttock and spreads to involve the other regions of the same and then opposite side and is due to multifocal involvement of lumbosacral roots, plexus, and peripheral nerve (i.e., diabetic lumbosacral radiculoplexus neuropathy). 2) Motor, sensory, and autonomic fibers are all involved. 3) Ischemic injury explains the clinical features and pathologic abnormalities of nerve. 4) The proximate cause of the ischemic injury appears to be microscopic vasculitis. 5) The segmental demyelination is probably secondary to ischemic axonal dystrophy, thus providing a unifying hypothesis for both axonal degeneration and segmental demyelination.
Key words: Diabetes mellitusPeripheral neuropathyNecrotizing vasculitisIschemiaDiabetic amyotrophyProximal diabetic neuropathyLumbosacral plexopathy.
This article has been cited by other articles:
![]() |
R. S. Laughlin, P. J. Dyck, L. J. Melton III, C. Leibson, J. Ransom, and P.J.B. Dyck Incidence and prevalence of CIDP and the association of diabetes mellitus Neurology, July 7, 2009; 73(1): 39 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
M P T Lunn and H J Willison Diagnosis and treatment in inflammatory neuropathies J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 249 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawagashira, H. Watanabe, Y. Oki, M. Iijima, H. Koike, N. Hattori, M. Katsuno, F. Tanaka, and G. Sobue Intravenous immunoglobulin therapy in proximal diabetic neuropathy BMJ Case Reports, January 22, 2009; 2009(jan21_1): bcr0820080656 - bcr0820080656. [Abstract] [Full Text] |
||||
![]() |
K C Gorson, D N Herrmann, R Thiagarajan, T H Brannagan, R L Chin, L J Kinsella, and A H Ropper Non-length dependent small fibre neuropathy/ganglionopathy J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 163 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Kawagashira, H Watanabe, Y Oki, M Iijima, H Koike, N Hattori, M Katsuno, F Tanaka, and G Sobue Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 899 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Muley, G. J. Parry, and N. G. Ercan-Fang Isolated Bibrachial Plexopathy in a Patient With Type 2 Diabetes Diabetes Care, October 1, 2005; 28(10): 2591 - 2592. [Full Text] [PDF] |
||||
![]() |
J.-E. Lee, C.-T. Shun, S.-C. Hsieh, and S.-T. Hsieh Skin Denervation in Vasculitic Neuropathy Arch Neurol, October 1, 2005; 62(10): 1570 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Thaisetthawatkul, M. L. Collazo-Clavell, M. G. Sarr, J. E. Norell, and P. J.B. Dyck A controlled study of peripheral neuropathy after bariatric surgery Neurology, October 26, 2004; 63(8): 1462 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.M. Boulton, R. A. Malik, J. C. Arezzo, and J. M. Sosenko Diabetic Somatic Neuropathies Diabetes Care, June 1, 2004; 27(6): 1458 - 1486. [Full Text] [PDF] |
||||
![]() |
G. Said, C. Lacroix, P. Lozeron, A. Ropert, V. Plante, and D. Adams Inflammatory vasculopathy in multifocal diabetic neuropathy Brain, February 1, 2003; 126(2): 376 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Koski Therapy of CIDP and related immune-mediated neuropathies Neurology, December 24, 2002; 59(90126): S22 - 27. [Abstract] [Full Text] |
||||
![]() |
C J Klein, P J B Dyck, S M Friedenberg, T M Burns, A J Windebank, and P J Dyck Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy J. Neurol. Neurosurg. Psychiatry, July 1, 2002; 73(1): 45 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Wiles, P Brown, H Chapel, R Guerrini, R A C Hughes, T D Martin, P McCrone, J Newsom-Davis, J Palace, J H Rees, et al. Intravenous immunoglobulin in neurological disease: a specialist review J. Neurol. Neurosurg. Psychiatry, April 1, 2002; 72(4): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A C Hughes Regular review: Peripheral neuropathy BMJ, February 23, 2002; 324(7335): 466 - 469. [Full Text] [PDF] |
||||
![]() |
P. J. B. Dyck, J. E. Norell, and P. J. Dyck Non-diabetic lumbosacral radiculoplexus neuropathy: Natural history, outcome and comparison with the diabetic variety Brain, June 1, 2001; 124(6): 1197 - 1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Collins, J. R. Mendell, M. I. Periquet, Z. Sahenk, A. A. Amato, G. S. Gronseth, R. J. Barohn, C. E. Jackson, and J. T. Kissel Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy Neurology, September 12, 2000; 55(5): 636 - 643. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |